Clinical Trial Update: Capecitabine in Treating Patients With Malignant Mesothelioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating capecitabine for malignant mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED